Ipamorelin 10mg
99.395% HPLC PurityA selective pentapeptide growth-hormone secretagogue (GHRP).

SKU: PEP-041-10MG
The 29-amino-acid N-terminal fragment of GHRH, supplied as a 10mg lyophilised vial. Research use only. Preorder — ships with the first batch.
Read the full description ↓Price includes GST
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Preorder: dispatched once the next batch arrives, tracked with Australia Post
A selective pentapeptide growth-hormone secretagogue (GHRP).
A stabilised analogue of growth-hormone-releasing hormone (GHRH).
The long-acting GHRH analogue on its own, without the Ipamorelin pairing.
The 29-amino-acid N-terminal fragment of GHRH, supplied as a 10mg lyophilised vial.
It has been studied extensively as a reference GHRH receptor agonist in growth hormone axis research.
This product is currently available to preorder and ships once the first batch has been produced and tested. Strictly for in-vitro laboratory research only.
The 29-amino-acid N-terminal fragment of GHRH, supplied as a 10mg lyophilised vial. It has been studied extensively as a reference GHRH receptor agonist in growth hormone axis research. All use is strictly for in-vitro laboratory research only.
This product is a preorder. It is not held in stock yet and ships with the first batch; you will be emailed when your order is dispatched.
Batch testing documentation is published for each batch once it has been produced and tested. Contact us before ordering if you need it first.
Store lyophilised product at −20°C, protected from light and moisture, and avoid repeated freeze-thaw cycles.
No. Sermorelin is supplied for in-vitro laboratory research only and is not approved for human consumption or therapeutic use. Scheduling attaches to the substance and changes over time; verify the current status against the TGA Poisons Standard.
Sermorelin Acetate 10mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
No questions yet — be the first to ask about this product.
Recent peer-reviewed studies from PubMed related to Sermorelin. Provided for research context — not medical advice.
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Rahman OF, Lee SJ, Seeds WA · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
PMID: 41490200
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Mendias CL, Awan TM · Sports medicine (Auckland, N.Z.) · 2026
PMID: 41966639
Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?
Walker RF · Clinical interventions in aging · 2006
PMID: 18046908
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review
Coutinho LFD, DE Oliveira Neves LF, Camilo RP · The Journal of sports medicine and physical fitness · 2026
PMID: 41880199
Source: U.S. National Library of Medicine (PubMed). Citations are fetched live and cached; inclusion does not imply endorsement of any therapeutic use.